Author: Dr. David Lowemann

Potential epigenetic biomarker found for preeclampsia in pregnancy

Analysis of cheek swabs taken from pregnant women revealed a potential epigenetic biomarker for preeclampsia, a potentially life-threatening condition that often leads to preterm births. While a clinical trial is needed to confirm the results, a study offers hope that a simple test can be developed to identify preeclampsia earlier in pregnancy. Currently preeclampsia is […]

Published on December 5, 2024

Food allergy anxiety at 30,000 feet

The skies aren’t always so friendly for patients and families affected by food allergies, who may often experience worry and anxiety regarding airline travel, according to a new study. Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he […]

Published on December 5, 2024

FDA Chief Defends Work on Obesity, Food to Senate

U.S. Food and Drug Administration Commissioner Robert Califf defended the agency’s role in addressing the country’s obesity epidemic as he was grilled by senators over FDA regulation of the food and beverage industry on Thursday. The hearing of the Senate Committee on… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is […]

Published on December 5, 2024